Effectiveness of belimumab in reducing disease activity in patients with refractory systemic lupus erythematosus: Real-world evidence. // Medicina Clínica (English Edition). – URL: https://www.sciencedirect.com/science/article/pii/S2387020626004316?dgcid=rss_sd_all
Effectiveness of belimumab in reducing disease activity in patients with refractory systemic lupus erythematosus: Real-world evidence. Medicina Clínica (English Edition). https://www.sciencedirect.com/science/article/pii/S2387020626004316?dgcid=rss_sd_all
“Effectiveness of belimumab in reducing disease activity in patients with refractory systemic lupus erythematosus: Real-world evidence.” Medicina Clínica (English Edition).
@article{article100975,
title = {Effectiveness of belimumab in reducing disease activity in patients with refractory systemic lupus erythematosus: Real-world evidence},
journal = {Medicina Clínica (English Edition)},
url = {https://www.sciencedirect.com/science/article/pii/S2387020626004316?dgcid=rss_sd_all}
}
Publication date: November–December 2026 Source: Acta Otorrinolaringologica (English Edition), Volume 77, Issue 6 Author(s): Daniel Álvarez de Castro, Sandra Pérez de la Iglesia, Miguel Ramírez Verdyguer, Francisco José Manzano Gómez